Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06710145

The Effect of Using the Combat Attention App on the Risk of Post-traumatic Symptoms

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Tel Aviv University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Military service and reserve duty in combat units entails exposure to traumatic events that require mental adjustment. In light of the results of controlled studies that proved the effectiveness an response-time based mechanized training protocol in reducing risk for post-trauma symptoms in deployed combat soldiers, the Israeli Defense Forces decided at the beginning of the Iron Swords War to implement an internet-based App of the intervention. Soldiers and combat reservists were invited to use the Combat Attention App. The purpose of this study is to examine the effectiveness of the Combat Attention App in relation to a control group of soldiers who did not use the App in reducing risk for post-traumatic stress symptoms of deployed soldiers.

Detailed description

Participants who used the Combat Attention App before combat deployment and a group of matched (age and sex) participants who did not use the App will be compared on PTSD, depression, and anxiety symptoms post deployment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCombat Attention TrainingThe Combat Attention App is a response-time based mechanized preventive intervention designed to train combat soldiers' attention toward threats before combat exposure in order to reduce the risk for combat-related post-trauma symptoms. In light of the results of controlled studies that proved the efficacy of this preventive intervention, the Israel Defense Forces (IDF) decided at the beginning of the Iron Swords War (October 7th, 2023) to implement an internet-based App of the intervention, and soldiers and combat reservists were invited to train on the Combat Attention App.

Timeline

Start date
2026-01-01
Primary completion
2026-06-30
Completion
2026-12-31
First posted
2024-11-29
Last updated
2025-04-11

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT06710145. Inclusion in this directory is not an endorsement.